![\"\"](\"\/en\/wp-content\/uploads\/2021\/08\/logo2.png\"){kind=logo}
<\/p>\n<\/p>\n
Cancer is a highly complex disease with multiple mutations and various molecular targets, making it a challenge to treat effectively. Unfortunately, many current therapies fail to address important aspects of the disease, such as tumor metabolism regulation and immune system enhancement. As a result, these therapies often induce resistance, require dose increases, and have high toxicity and collateral effects such as mucositis or cardiopathy.<\/p>\n
Additionally, their high cost and limited access mean that many patients are unable to benefit from them.<\/p>\n<\/div>\n
Cancer causes about 9.6 million deaths worldwide. The current therapies are expensive, have limited access and present problems such as resistance, high toxicity and severe side effects as drug resistance, high toxicity and serious side\u00a0effects\u00a0.<\/p>\n<\/div>\n<\/div>\n
Polymolecular drugs based on natural extracts that offer multiple bene\ufb01ts in the treatment of cancer, including reduction of in\ufb02ammation, modulation of energetic metabolism and activation of the immune system.<\/p>\n<\/div>\n<\/div>\n
With over 18 years of research experience, our team has created medicines acting as an endogenous vaccine.<\/p>\n
Our medicines reduce recovery time and improve the well-being of cancer patients. We offer new hope for a full recovery and a better quality of life.<\/p>\n<\/div>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/ml1.jpg\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/sharing.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/inmune-system.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/network.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/iv-bag.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/ml2.jpg\")
<\/p>\n
With 12 patents and research spanning over 18 years, the medicines developed by Dreembio have shown, over multiple studies and trials a remarkable reduction in cancer tumor size by up to 75% and 3.7 times in metastasis for breast cancer, melanoma, and leukemia in mice models. US 9M in grants and several awards.<\/p>\n<\/div>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/certificate.png\")
\n![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/ml4.jpg\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/money.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/secure.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/ribbon.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/doctors.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/research.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/network-1.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/equality.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/ml5.png\")
<\/p>\n
![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/team1.jpg\")
<\/p>\n
Scientific Director, Founder.<\/p>\n
PhD – Titular II Professor. Immunology and Oncology. Leader of the scientific team with more than 29 years of experience in R&D.<\/p>\n
Colombian-French nationality<\/em><\/p>\n<\/div>\n<\/li>\n International Business and Associations<\/p>\n More than 25 years of experience in the creation of technology-based companies, serial entrepreneur. Founder of Simply Agave, Stelagenomics, Orfanbio Clearwater Network, and FlowStorm.<\/p>\n<\/div>\n<\/li>\n Financial Advisor<\/p>\n Senior C-level executive, with solid experience in corporate finance, international business development, and portfolio management in commercial and investment banking and real sectors, as well as advising a government seed capital fund.<\/p>\n<\/div>\n<\/li>\n Director of R&D<\/p>\n Doctor in Immunology, more than 15 years of experience in basic and clinical research in cancer and phytotherapy..<\/p>\n<\/div>\n<\/li>\n Technical Director<\/p>\n Pharmaceutical Chemist with a Master\u2019s Degree in Science and Economics. Extensive experience and contacts in the Colombian pharmaceutical industry.<\/p>\n<\/div>\n<\/li>\n Chief of Operations<\/p>\n Business administrator with more than 7 years of experience in strategic planning, sales, and customer service.<\/p>\n<\/div>\n<\/li>\n IP Advisor<\/p>\n More than 15 years of experience advising universities and companies on the protection of their intellectual property as well as technology transfer.<\/p>\n<\/div>\n<\/li>\n Cosmetic ingredients Export-import<\/p>\n Founder of several companies and CEO of an Paris-based international trade company related to fresh products with more than 30 years of experience..<\/p>\n<\/div>\n<\/li>\n Corporate Governance and Chemical Laboratory.<\/p>\n![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/team2.jpg\")
<\/p>\nAdolfo Nemirosky<\/h3>\n
\n![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/team3.jpg\")
<\/p>\nFrancisco Barnier<\/h3>\n
\n![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/team4.jpg\")
<\/p>\nClaudia Urue\u00f1a<\/h3>\n
\n![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/team5.jpg\")
<\/p>\nRicardo Ballesteros<\/h3>\n
\n![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/team6.jpg\")
<\/p>\nCarolina \u00c1vila<\/h3>\n
\n![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/team7.jpg\")
<\/p>\nMario Ortega<\/h3>\n
\n![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/team8.jpg\")
<\/p>\nJavier Barnier<\/h3>\n
\n![\"\"](\"\/en\/wp-content\/uploads\/2023\/12\/team9.jpg\")
<\/p>\nMartha Forero<\/h3>\n
![\"\"](\"\/en\/wp-content\/uploads\/2022\/06\/video1.jpg\")
<\/a>![\"\"](\"\/en\/wp-content\/uploads\/2022\/06\/icon-play.svg\"){kind=icon}
<\/p>\n![\"\"](\"\/en\/wp-content\/uploads\/2021\/08\/fav.png\")
<\/p>\n